sibrafiban
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The initiating event of acute coronary syndromes is atherosclerotic plaque rupture followed by local thrombosis. Antithrombotic…
Received May 18, 2004; revision received June 21, 2004; accepted August 4, 2004.
Remarkable advances in cardiovascular care…
CAN OBSERVATIONAL DATA SUBSTITUTE FOR RANDOMized controlled trials for developing treatment recommendations and initiating public…
Secondary prevention of stroke and other manifestations of atherothrombosis is essential if the burden of disease associated with…
Sibrafiban is a double prodrug that is converted to the inactive single prodrug and to the active GP IIb/IIIa antagonist after…
Sibrafiban is the orally administered, nonpeptide. double-prodrug of Ro 44-3888 which is a selective glycoprotein IIb/IIIa…
BACKGROUND
Despite progress, atherosclerotic vascular disease remains a major cause of morbidity and mortality. Intravenous…
Sibrafiban is a double prodrug that is converted to the inactive single prodrug and to the active IIb/IIIa antagonist following…